drugset / Trial / NCT00003198

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

NCT00003198

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy with ifosfamide and topotecan in treating patients with refractory solid tumors.

Timeline

Start
1997-11
Primary completion
2000-05
Completion
2000-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ifosfamide Small molecule
Subject Topotecan Small molecule